BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Bayer HealthCare Pharmaceuticals 

340 Changebridge Road
Pine Brook, New Jersey 07058 U.S.A.

Phone: 973-487-2000

800 Dwight Way

Berkeley  California  94701  U.S.A.
Phone: 510-705-5000 Fax: 510-705-7878


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Bayer HealthCare Pharmaceuticals (BAYA.F), Onyx Pharmaceuticals, Inc. (ONXX)'s Nexavar Misses Target In Phase 3 Liver Cancer Trial 3/11/2014 6:25:33 AM    More...
Bayer HealthCare Pharmaceuticals (BAYA.F)' Long-Acting Hemophilia Drug Shown To Be Effective 2/18/2014 7:37:07 AM    More...
Bayer HealthCare Pharmaceuticals (BAYA.F) to Present Data Investigating Recently Approved Adempas® (riociguat) Tablets 10/28/2013 11:09:30 AM    More...
FDA Approves Bayer HealthCare Pharmaceuticals (BAYA.F)'s New Class of Drug Adempas® (riociguat) Tablets to Treat Adults With PAH and Persistent, Recurrent or Inoperable CTEPH 10/9/2013 6:51:11 AM    More...
FDA Advisory Panel Backs Bayer HealthCare Pharmaceuticals (BAYA.F)'s Riociguat for Lung Disease 8/6/2013 2:57:29 PM    More...
Bayer HealthCare Pharmaceuticals (BAYA.F) Release: The New England Journal of Medicine Publishes Results From the Phase III ALSYMPCA Study of Xofigo® (Radium Ra 223 Dichloride) Injection 7/18/2013 8:35:34 AM    More...
Bayer HealthCare Pharmaceuticals (BAYA.F) and Onyx Pharmaceuticals, Inc. (ONXX) Announce Submission of FDA and European Medicines Agency Applications for Nexavar® (sorafenib) for the Treatment of Radioactive Iodine-Refractory Differentiated Thyroid Cancer 7/1/2013 10:52:25 AM    More...
Bayer HealthCare Pharmaceuticals (BAYA.F), Onyx Pharmaceuticals, Inc. (ONXX)'s Liver Cancer Drug Nexavar Slows Rare Thyroid Tumor 6/3/2013 7:22:16 AM    More...
Bayer HealthCare Pharmaceuticals (BAYA.F) to Present New Data Across Oncology Portfolio at American Society of Clinical Oncology 2013 5/16/2013 7:01:39 AM    More...
Bayer HealthCare Pharmaceuticals (BAYA.F) Initiates Phase III Trial of Stivarga® (regorafenib) Tablets in Patients with Advanced Liver Cancer 5/15/2013 9:10:49 AM    More...
12345678910